Researchers have found that people with Laron syndrome have a lower incidence of cancer than the wider population.

As of Monday, July 20, Viridian Therapeutics, Inc.’s VRDN share price has surged by 5.05%, which has investors questioning if ...

Context is important when discussing the benefits of a specific intervention for health and fitness. In an era of headline reading, it’s good to get in the habit of asking more questions. Even ...

When Mriganka Sur was a student at IIT Kanpur, there was no neuroscience department. Today, IISc Bengaluru, NIMHANS, and Haryana’s National Brain Research Centre are investigating the complexities of ...

Across Australia, “longevity” and “wellness” clinics, most of them online, sell injections that promise to slow ageing, build ...

As a Gen Xer who lived through the “heroin chic” years, when skeletal models were celebrated for jutting bones and sallow ...

Insulin resistance is one area under investigation. If you have been diagnosed with the condition, here’s how GLP-1s may help ...

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians ...

Viridian Therapeutics (VRDN) has drawn fresh investor attention after recent trading left the stock at $19.08. Recent ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...